Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity

Proteasome inhibitors have distinct properties and the biochemical consequences of suppressing ubiquitin E1 enzymes and the proteasome differ. We compared the effects of the proteasome inhibitors bortezomib, ixazomib and carfilzomib and the ubiquitin E1 enzyme inhibitor MLN7243/TAK-243 on cell viabi...

Descripción completa

Detalles Bibliográficos
Autores principales: McHugh, Angela, Fernandes, Kenneth, South, Andrew P., Mellerio, Jemima E., Salas-Alanís, Julio C., Proby, Charlotte M., Leigh, Irene M., Saville, Mark K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945540/
https://www.ncbi.nlm.nih.gov/pubmed/29755650
http://dx.doi.org/10.18632/oncotarget.24750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945540/
https://www.ncbi.nlm.nih.gov/pubmed/29755650
http://dx.doi.org/10.18632/oncotarget.24750

Ejemplares similares